Skip to content

AtriCure

US · ATRC #2543 by market cap Listed 1970
55.39 +1.28 +2.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 40 in the most recent period (2026/Q3).
  • Total institutional ownership rose 9.0 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
114.67% +9.03pp
Institutions
350 +40
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund96.13%
Hedge Fund11.53%
Individual/Insider3.98%
Public Company2.85%
Government Pension Fund1.40%
Private Company0.99%
Insurance Company0.93%
Sovereign Wealth Fund0.74%

Top holders as of 2026-09-30

BlackRock 15.39% · 7.84M sh
Vanguard Portfolio Management, LLC 7.12% · 3.63M sh
Wellington Management Group 6.86% · 3.50M sh
Hood River Capital Management LLC 5.71% · 2.91M sh
AllianceBernstein 5.44% · 2.77M sh
Vanguard Capital Management, LLC 4.31% · 2.19M sh
State Street Global Advisors 4.18% · 2.13M sh
Macquarie Investment Management Business Trust 3.41% · 1.73M sh
Goldman Sachs Asset Management, L.P. 2.91% · 1.48M sh
Marshall Wace LLP 2.62% · 1.33M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 22 buys · 28 sells

NameRoleStake
Michael Carrel Chief Executive Officer 1.56%
Douglas Seith Chief Operating Officer 0.45%
Angela Wirick Chief Financial Officer 0.40%
Salvatore Privitera Chief Technology Officer 0.26%
Robert White Independent Chairperson 0.25%
Justin Noznesky Chief Marketing & Strategy Officer 0.20%
Karl Dahlquist Chief Legal Officer 0.17%
Vinayak Doraiswamy Chief Scientific Officer 0.17%
B. Johnson Independent Director 0.11%
Deborah Yount Former Chief Human Resources Officer 0.09%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-05 B. Johnson Independent Director Open Market Disposition -2,452 $58.48
2026-11-03 Salvatore Privitera Chief Technology Officer Automatic Disposition -8,404 $65.00
2026-09-22 Salvatore Privitera Chief Technology Officer Automatic Disposition -4,519 $60.00
2026-09-10 Regina Groves Independent Director Open Market Disposition -5,313 $54.22
2026-09-09 Regina Groves Independent Director Intent to Sell (Form 144) -5,313 $53.66
2026-09-07 Salvatore Privitera Chief Technology Officer Automatic Disposition -3,657 $55.00
2026-09-01 Salvatore Privitera Chief Technology Officer Automatic Disposition -7,763 $52.50
2026-08-23 Karl Dahlquist Chief Legal Officer Open Market Disposition -9,370 $48.89
2026-08-04 Karen Prange Independent Director Open Market Disposition -3,564 $38.80
2026-08-04 Maggie Yuen Independent Director Open Market Disposition -3,500 $38.42
2026-07-29 Michael Carrel Chief Executive Officer Other Disposition -4,700 --
2026-07-28 Justin Noznesky Chief Marketing & Strategy Officer Open Market Disposition -6,182 $38.80
2026-07-27 Sven Wehrwein Independent Director Derivative Exercise and Sale -25,000 $19.95–37.84
2026-07-27 Vinayak Doraiswamy Chief Scientific Officer Open Market Disposition -6,000 $38.88
2026-06-29 Michael Carrel Chief Executive Officer Other Acquisition +636 $23.78
2026-06-29 Salvatore Privitera Chief Technology Officer Other Acquisition +636 $23.78
2026-06-29 Douglas Seith Chief Operating Officer Other Acquisition +527 $23.78
2026-06-29 Karl Dahlquist Chief Legal Officer Other Acquisition +636 $23.78
2026-06-29 Vinayak Doraiswamy Chief Scientific Officer Other Acquisition +636 $23.78
2026-05-19 Karen Prange Independent Director Open Market Disposition -3,000 $28.65

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

AtriCure discussion 0 comments

Add a comment